Grifols S.A.

Grifols S.A.

World Rank (Jan-05-2024)
1,723
Market Cap (Jan-05-2024)
9.535 Billion USD
World Rank (Jul-30-2023)
1,788
Market Cap (Jul-30-2023)
9.235 Billion USD
World Rank (Jan-07-2022)
1,735
Market Cap (Jan-07-2022)
11.020 Billion USD
World Rank (Jan-01-2021)
1,037
Market Cap (Jan-01-2021)
17.417 Billion USD
Headquarters Country
Spain
Nasdaq / NYSE Code
GRFS
Employee Count
26,314
Employee Count as of Date
As on 2022
Headquarters City/State
Barcelona
World Region
Europe
World Subregion
Southern Europe
Annual Revenue in USD
6,685 Million USD
Annual Operating Income in USD
774 Million USD
Annual Net Income in USD
229 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
23,741 Million USD
Total Liabilities in USD
14,417 Million USD
Total Equity in USD
9,324 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
GRIFOLS S.A.
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

Annual Results Summary

GRIFOLS - Annual Results - Revenue and Net Income - in Million EUR:

Year - EndingRevenueNet Profit
Dec-20226,063208
Dec-20214,933182
Dec-20205,340708
Dec-20195,098625
Balance Sheet Summary

Total Assets as on Dec-2022 is 21,533 Million EUR.

Total Liabilities as on Dec-2022 is 13,076 Million EUR.

Total Equity as on Dec-2022 is 8,457 Million EUR.

Founded Year
1940
Stock Category
S&P EUROPE 350
Stock Exchange
Nasdaq
MCE
Company SubCategory
Top Healthcare Companies in Europe
Top Pharmaceutical Companies in Europe
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share